Patent: 7,303,746
✉ Email this page to a colleague
Summary for Patent: 7,303,746
Title: | Methods of treating eye disorders with modified chimeric polypeptides |
Abstract: | Modified chimeric polypeptides with improved pharmacokinetics are disclosed useful for treating eye disorders, including age-related macular degeneration and diabetic retinopathy. |
Inventor(s): | Wiegand; Stanley J. (Croton on Hudson, NY), Papadopoulos; Nicholas (LaGrangeville, NY), Yancopoulos; George D. (Yorktown Heights, NY) |
Assignee: | Regeneron Pharmaceuticals, Inc. (Tarrytown, NY) |
Application Number: | 10/988,243 |
Patent Claims: | see list of patent claims |
Details for Patent 7,303,746
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Regeneron Pharmaceuticals, Inc. | EYLEA | aflibercept | Injection | 125387 | 11/18/2011 | ⤷ Try a Trial | 2039-02-26 |
Regeneron Pharmaceuticals, Inc. | EYLEA | aflibercept | Injection | 125387 | 08/16/2018 | ⤷ Try a Trial | 2039-02-26 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 7,303,746
Country | Patent Number | Estimated Expiration |
---|---|---|
Argentina | 044938 | ⤷ Try a Trial |
Austria | 293164 | ⤷ Try a Trial |
Austria | 417928 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |